128 related articles for article (PubMed ID: 12064872)
1. p53 gene mutation and MDM2 overexpression in a case of primary malignant fibrous histiocytoma of the jejunum.
Jiao YF; Nakamura S; Sugai T; Habano W; Uesugi N; Oikawa M; Sato T
APMIS; 2002 Feb; 110(2):165-71. PubMed ID: 12064872
[TBL] [Abstract][Full Text] [Related]
2. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.
Molina P; Pellín A; Navarro S; Boix J; Carda C; Llombart-Bosch A
Virchows Arch; 1999 Dec; 435(6):596-605. PubMed ID: 10628802
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
4. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma.
Reid AH; Tsai MM; Venzon DJ; Wright CF; Lack EE; O'Leary TJ
Diagn Mol Pathol; 1996 Mar; 5(1):65-73. PubMed ID: 8919547
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
6. Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamide.
Schlott T; Taubert H; Fayyazi A; Schweyer S; Bartel F; Korabiowska M; Brinck U
Anticancer Res; 2004; 24(6):3819-29. PubMed ID: 15736417
[TBL] [Abstract][Full Text] [Related]
7. G-CSF producing malignant fibrous histiocytoma in the jejunum: a case report.
Umehara M; Watanabe A; Umehara M; Matsumoto S; Saito T; Naito Z
Hepatogastroenterology; 2000; 47(36):1630-2. PubMed ID: 11149020
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MDM2 in a sclerosing epithelioid fibrosarcoma: genetic, immunohistochemical and ultrastructural study of a case.
Jiao YF; Nakamura S; Sugai T; Uesugi N; Habano W; Ogata M; Fujioka T
Pathol Int; 2002 Feb; 52(2):135-40. PubMed ID: 11940218
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
[TBL] [Abstract][Full Text] [Related]
10. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
Li J; Yang G; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
12. [Role of functional inactivation of p53 from MDM2 overexpression in hepatocarcinogenesis].
Luo YL; Cheng RX; Feng DY
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):13-6. PubMed ID: 12536604
[TBL] [Abstract][Full Text] [Related]
13. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
14. Primary malignant fibrous histiocytoma of the jejunum: report of a case and review of subject.
Córdoba Díaz de Laspra E; Calleja JL; Hernando E; Lahuerta L; Ceballos C; Cardiel MJ; del Río Marco F; Ferreira Montero V
J R Coll Surg Edinb; 1997 Oct; 42(5):355-8. PubMed ID: 9354075
[TBL] [Abstract][Full Text] [Related]
15. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
[TBL] [Abstract][Full Text] [Related]
16. A p53 gene mutation in malignant fibrous histiocytoma associated with bone infarction.
Yamamoto Y; Takakuwa Y; Kuroda M; Nakashima H; Washimi Y; Ishimura D; Yamada H
Tohoku J Exp Med; 2011 Nov; 225(3):215-20. PubMed ID: 22041521
[TBL] [Abstract][Full Text] [Related]
17. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma.
Segers K; Backhovens H; Singh SK; De Voecht J; Ramael M; Van Broeckhoven C; Van Marck E
Virchows Arch; 1995; 427(4):431-6. PubMed ID: 8548129
[TBL] [Abstract][Full Text] [Related]
20. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
